| Product Name | NebuSelect™ Recombinant Human EMMPRIN/CD147, His-tag |
|---|---|
| Catalog Number | NBL-242702 |
| Alias/Synonyms | EMMPRIN/CD147; Basigin; BSG; CD147; 5F7; M6; OK; TCSF |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | NP_940991.1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242702-100ug | 100ug | Inquire | Inquire | |
| NBL-242702-1mg | 1mg | Inquire | Inquire | |
| NBL-242702-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human EMMPRIN/CD147, His-tag
Catalog#:
NBL-242702
Description:
NebuSelect™ Recombinant Human EMMPRIN/CD147, His-tag(Cat#NBL-242702) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala22-His205.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 21.2 kDa. Due to glycosylation, the protein migrates to 28-40 kDa based on Bis-Tris PAGE result.
Target Name:
EMMPRIN/CD147; Basigin; BSG; CD147; 5F7; M6; OK; TCSF
Target Information:
CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation of extracellular matrix (ECM) remodeling during physiological and pathological processes including wound healing, inflammatory diseases, and cancer. CD147 is a diagnostic and therapeutic target in cancer and inflammatory diseases, either directly or indirectly, by targeting CD147 partners.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.